to ymav4294: ct scan frequency and pfs results, page-13

Hi Nuts et al,

Looking back, Provenge and Yerevoy were approved for sale by the FDA and subsequently got their health fund subsidies on the basis of Median PFS benefit around 4 months, from their Phase 3 trials.

On that basis, I'm hoping we see a similar result for Cvac in the Phase 2b trial result. That should please the market and anything better would be just gravy.

One way or another, only about 4 weeks till the result is released.

Conjecture that the results have been leaked to some are just hogwash IMO. There's an independant authority that collects the patient data from the various collection centres and carries out the analysis prior to sending it to PRR. I doubt very much if that has been completed yet.